Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vascular Cell Activation Throughout Ovarian Hyperstimulation for In Vitro Fertilisation: Role of Cell-Derived Microparticles in the Adverse Outcomes

NCT03051230 is registered in ClinicalTrials.gov with Poissy-Saint Germain Hospital as lead sponsor.

NCT NCT03051230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03051230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vascular Cell Activation Throughout Ovarian Hyperstimulation for In Vitro Fertilisation: Role of Cell-Derived Microparticles in the Adverse Outcomes
Lead sponsor
Poissy-Saint Germain Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2012
Completion date
February 1, 2017
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperstimulation syndrome, ovaian, infertility, thrombosis